Cell BioEngines, Inc

A clinical-stage biotech company developing allogeneic ‘off-the-shelf’ stem cell-derived therapies as ‘drugs’ for human disease treatment

[Cell BioEngines, Inc @cell_bioengines]

Great turnout for the CCS inaugural CGT Summer Symposium today! Thank you New York Blood Center for putting together a great panel and this opportunity for us to come together for CGT specific industry discussions.

#nextgeneration #celltherapies #oncology #regenerativemedicine

[Cell BioEngines, Inc @cell_bioengines]

Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies https://t.co/ybFbfx5knQ

[Cell BioEngines, Inc @cell_bioengines]

https://t.co/ZFpOIwbKO9

[Cell BioEngines, Inc @cell_bioengines]

Panel: The Entrepreneurs Journey 👣 ⛰ // Mon, Sep 30th

[Dr. Ajay Vishwakarma @VishwakarmaAJ]

Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures https://t.co/genQqfyCbO

[Cell BioEngines, Inc @cell_bioengines]

Exciting News! 🎉 We are thrilled to announce the newest funding from @SOSV and @EmpireStateDev New York Ventures!

https://t.co/Zqsw7bSNkV

[channel✨💖 @harlee_luv008]

What a group! Congrats @MiriamMerad @BhardwajLab !

[Cell BioEngines, Inc @cell_bioengines]

@exosome https://t.co/YVWD6FVwQu

[SOSV - Deep Tech for Human and Planetary Health @SOSV]

Just published the third annual SOSV's Human Health 100 ⚕️with 16 new additions. Valuations and funds raised are steady. 52 startups are @indbio grads and 38 are @hax_co alums. Among the founders, 70% have a pHD and 35% are women. https://t.co/mOKmt9nRni

[Cell BioEngines, Inc @cell_bioengines]

Hooray!! @cell_bioengines Inc made it to the 2024 SOSV’s Human Health 100. Congrats to the entire team!

[NYCEDC @NYCEDC]

.@cell_bioengines will be presenting at the BIO CEO & Investor Conference at 2:00 p.m. EST on Monday, February 26, 2024!

To register and learn more visit: https://t.co/H9goCRVgsI

[SOSV SF & NY (Fka IndieBio) @indbio]

Please read Sean's take on where deep tech is headed and why it's bound to accelerate, despite VC woes.

[Cell BioEngines, Inc @cell_bioengines]

Cell BioEngines to Unveil Revolutionary Stem Cell Therapies at BIO CEO & Investor Conference https://t.co/rESfgUN094

[Sean O'Sullivan @sean_os1]

That's a great list of biotech investors.

But @SOSV & IndieBio (@indbio) are really the same investor... (SOSV is what appears on the cap table). This just means, probably, that @hax_co, SOSV's other deep-tech arm, invested in 4 more biotech firms that IndieBio didn't, in the quarter.

So everyone else, you're really one higher up on the list if you take out SOSV being in the top two positions.

Biotech's rapid recovery is a good indicator for tech in general. Hoping we see this rebound broaden out for all VC in 2024.

[Cell BioEngines, Inc @cell_bioengines]

Fantastic story of Prof. Bhardwaj Nina starting from her post-doc days at Nobel Prize winner Ralph Steinman's lab to now becoming a pioneer in developing cancer vaccines.@cell_bioengines is superproud to leverage her technology and expertise in dendritic cell-based cDC1 vaccine!

[Parker Institute for Cancer Immunotherapy @parkerici]

🎙 Ep. 5 of From Bench to Fireside™ #podcast ft. #PICINetwork Investigator @BhardwajLab @MountSinaiNYC w/ @John_E_Connolly. They explore immune modulation, treatment evolution, personalized #vaccines with tumor-encoded mutant antigens and more! Listen➡️https://t.co/Fs8Qn1oRlT

[Cell BioEngines, Inc @cell_bioengines]

AstraZeneca to invest $300M in US cell therapy plant https://t.co/6hcU5LI9HR via @BioPharmaDive

[Cell BioEngines, Inc @cell_bioengines]

@John_E_Connolly @BhardwajLab @MountSinaiNYC @parkerici We're so proud to have an opportunity to translate her dendritic cell vaccine research work and bring to bedside!

[John Connolly @John_E_Connolly]

This was just a great discussion with the amazing Nina Bhardwaj, MD, PhD @BhardwajLab @MountSinaiNYC Part of @parkerici's “From Bench to Fireside”. Dr. Bhardwaj’s talks about her incredible research and the potential of cancer vaccines moving forward. https://t.co/dMK779ZfUq

[Cell BioEngines, Inc @cell_bioengines]

A big shout-out to @NYCEDC @SOSV for supporting us!

[Cell BioEngines, Inc @cell_bioengines]

Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference https://t.co/tIWxBt6Tcu via @YahooFinance

[Cell BioEngines, Inc @cell_bioengines]

Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference https://t.co/tIWxBt6Tcu via @YahooFinance